-
Is ChatGPT ready for orthopedic patients?
Three studies presented at the American Academy of Orthopedic Surgeon's 2024 conference examined the accuracy of artificial intelligence chatbots, such as ChatGPT, when it comes to providing accurate information for musculoskeletal patients. -
Ozempic's impact on total hip replacements
Two studies presented at the American Academy of Orthopedic Surgeon's 2024 conference examined the impact that the drug semaglutide, which is sold as Ozempic to treat Type 2 diabetes and as Wegovy for weight loss, could have on patients undergoing total hip arthroplasty. -
Orthopedic practice sues to keep regional hospitals open longer
Altoona, Wis.-based Chippewa Valley Orthopedics and Sports Medicine has sued Hospital Sisters Health System to keep Sacred Heart and St. Joseph’s hospitals in Eau Claire and Chippewa Falls, Wis., open until at least July 21. -
2024's orthopedic firsts
Just one month into 2024, orthopedic and spine specialists are already making waves with several 'firsts': -
Zimmer Biomet laying off 3% of staff as part of restructuring
Zimmer Biomet is laying off 3% of its workforce as part of a global restructuring that is expected to save the company $200 million by 2025, according to a statement to the Warsaw Times-Union published Feb. 5. -
3 orthopedic surgeons join Azra Care advisory board
Musculoskeletal artificial intelligence software provider Azra Care has added three orthopedic surgeons to its clinical advisory board. -
What's on the horizon for independent orthopedic practices?
In an increasingly consolidated landscape, independent orthopedic practices must get creative to stay afloat. -
The orthopedic practices facing data breach lawsuits
Cyberattacks come with several risks to orthopedic practices, from shut-down computer systems to patient lawsuits. -
MidJersey Orthopaedics building sells for $10.5M
A Bridgewater, N.J.-based medical office building anchored by MidJersey Orthopaedics has sold for $10.5 million, according to a Feb. 8 report from NJBiz. -
Rebound Orthopedics & Neurosurgery systems down
All external computer systems at Vancouver, Wash.-based Rebound Orthopedics & Neurosurgery have been shut down since Feb. 5, according to a Feb. 8 report from The Columbian. -
Meet the leadership team of Hospital for Special Surgery
Hospital for Special Surgery, an academic medical center focused on musculoskeletal health, was first incorporated in 1863 in New York City. The system's hospital has been named the No. 1 orthopedic hospital for 14 years in a row by U.S. News and World Report. -
Stryker family named among richest in America
The Stryker family, heirs of the orthopedic medtech company Stryker, have been named among the richest families in America, beating out legacy names like Rockefeller and Kennedy, according to a Feb. 8 report from Forbes. -
Zimmer Biomet sees Q4, 2023 sales rise
Zimmer Biomet on Feb. 8 posted fourth-quarter sales of $1.9 billion. -
3 orthopedic layoffs in 30 days: What it could mean for 2024
Healthcare layoffs were up 421% in January from the month prior, signaling the start of a potentially rocky year for the industry. -
Riverside Health System, Upfront Healthcare scale joint replacement partnership
Riverside Doctors' Hospital Williamsburg (Va.) has partnered with healthcare tech provider Upfront Healthcare since 2022 to deploy a unique platform for joint replacement cases, and the health system is expanding the program due to its success. -
Former lab CEO pleads guilty to fraud at orthopedic practice
Aaron Rossi, former CEO of Reditus Labs, has pleaded guilty to federal mail and tax fraud charges stemming from a scheme from when he was employed with Bloomington-based Central Illinois Orthopedic Surgery, according to a Feb. 6 report from NPR network WGLT. -
Why shoulder replacements are moving to ASCs
CMS has approved primary shoulder replacement surgeries to take place in the ASC setting as of Jan. 1. -
The best orthopedic EHRs for 2024, per Black Book
ModMed Exscribe has been named the top electronic health record system for orthopedic practices in 2024 by healthcare IT research firm Black Book Research. -
Weight loss drugs could increase orthopedic, decrease spine volume
The impacts of GLP-1 weight loss drugs like Ozempic and Wegovy on the orthopedic and spine industry are still largely unknown, with surgeons agreeing that it could take several years to fully see and understand their impact. -
Crovetti Orthopaedics adds Dr. Dylan Rogers
Las Vegas-based Crovetti Orthopaedics and Sports Medicine added Dylan Rogers, DO, to its staff.
Page 8 of 245